Judith Maxwell Silverman
Judith Maxwell Silverman
Brain Research Centre UBC
Verified email at mail.ubc.ca
Title
Cited by
Cited by
Year
An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages
JM Silverman, J Clos, CC de'Oliveira, O Shirvani, Y Fang, C Wang, ...
Journal of cell science 123 (6), 842-852, 2010
3932010
Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and-independent mechanisms
LI Grad, JJ Yerbury, BJ Turner, WC Guest, E Pokrishevsky, MA O’Neill, ...
Proceedings of the National Academy of Sciences 111 (9), 3620-3625, 2014
3252014
Proteomic analysis of the secretome of Leishmania donovani
JM Silverman, SK Chan, DP Robinson, DM Dwyer, D Nandan, LJ Foster, ...
Genome biology 9 (2), 1-21, 2008
2882008
Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles
F Martínez-Gutierrez, EP Thi, JM Silverman, CC de Oliveira, SL Svensson, ...
Nanomedicine: Nanotechnology, Biology and Medicine 8 (3), 328-336, 2012
2852012
Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells
JM Silverman, J Clos, E Horakova, AY Wang, M Wiesgigl, I Kelly, MA Lynn, ...
The Journal of Immunology 185 (9), 5011-5022, 2010
2532010
Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes
JM Silverman, NE Reiner
Cellular microbiology 13 (1), 1-9, 2011
2062011
Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection
JM Silverman, NE Reiner
Frontiers in cellular and infection microbiology 1, 26, 2012
1002012
Secreted virulence factors and immune evasion in visceral leishmaniasis
U Lambertz, JM Silverman, D Nandan, WR McMaster, J Clos, LJ Foster, ...
Journal of leukocyte biology 91 (6), 887-899, 2012
692012
Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways
JM Silverman, SM Fernando, LI Grad, AF Hill, BJ Turner, JJ Yerbury, ...
Cellular and molecular neurobiology 36 (3), 377-381, 2016
682016
Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit
WC Guest, JM Silverman, E Pokrishevsky, MA O'Neill, LI Grad, ...
Journal of Toxicology and Environmental Health, Part A 74 (22-24), 1433-1459, 2011
672011
Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase
D Nandan, CC de Oliveira, A Moeenrezakhanlou, M Lopez, JM Silverman, ...
The Journal of Immunology 188 (1), 367-378, 2012
632012
Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding
LI Grad, E Pokrishevsky, JM Silverman, NR Cashman
Prion 8 (5), 331-335, 2014
502014
CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1) G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1
JM Silverman, D Christy, CC Shyu, KM Moon, S Fernando, Z Gidden, ...
Journal of Biological Chemistry 294 (10), 3744-3759, 2019
432019
Identification of leishmania fructose-1, 6-bisphosphate aldolase as a novel activator of host macrophage Src homology 2 domain containing protein tyrosine phosphatase SHP-1
D Nandan, T Tran, E Trinh, JM Silverman, M Lopez
Biochemical and biophysical research communications 364 (3), 601-607, 2007
392007
A rationally designed humanized antibody selective for amyloid beta oligomers in Alzheimer’s disease
E Gibbs, JM Silverman, B Zhao, X Peng, J Wang, CL Wellington, ...
Scientific reports 9 (1), 1-14, 2019
142019
A rational structured epitope defines a distinct subclass of toxic amyloid-beta oligomers
JM Silverman, E Gibbs, X Peng, KM Martens, C Balducci, J Wang, ...
ACS chemical neuroscience 9 (7), 1591-1606, 2018
102018
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
J Robert, EB Button, EM Martin, L McAlary, Z Gidden, M Gilmour, G Boyce, ...
Molecular neurodegeneration 15 (1), 1-21, 2020
72020
[O2–14–03]: TARGETING OF TOXIC AMYLOID‐BETA OLIGOMER SPECIES BY MONOCLONAL ANTIBODY PMN310: PRECISION DRUG DESIGN FOR ALZHEIMER's DISEASE
J Kaplan, JM Silverman, E Gibbs, J Wang, X Peng, SS Plotkin, ...
Alzheimer's & Dementia 13 (7S_Part_11), P592-P592, 2017
52017
A COMPUTATIONAL METHOD TO PREDICT DISEASE-SPECIFIC EPITOPES IN Aβ, AND ITS APPLICATION TO OLIGOMER-SELECTIVE ANTIBODIES FOR ALZHEIMER’S IMMUNOTHERAPY
SS Plotkin, X Peng, JM Silverman, NR Cashman
Alzheimer's & Dementia 7 (12), P1148, 2016
52016
Achieving the optimal profile for Alzheimer’s immunotherapy: Rational generation of antibodies specific for toxic Aβ oligomers (P6. 084)
S Plotkin, E Gibbs, X Peng, J Silverman, N Cashman
Neurology 88 (16 Supplement), 2017
42017
The system can't perform the operation now. Try again later.
Articles 1–20